Literature DB >> 17492924

Targeted TGF-beta chemotherapies: friend or foe in treating human malignancies?

William P Schiemann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17492924     DOI: 10.1586/14737140.7.5.609

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


× No keyword cloud information.
  17 in total

Review 1.  The Cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cells.

Authors:  Tressa M Allington; William P Schiemann
Journal:  Cells Tissues Organs       Date:  2010-11-03       Impact factor: 2.481

Review 2.  Noncanonical TGF-β signaling during mammary tumorigenesis.

Authors:  Jenny G Parvani; Molly A Taylor; William P Schiemann
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-31       Impact factor: 2.673

Review 3.  The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.

Authors:  Molly A Taylor; Jenny G Parvani; William P Schiemann
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-15       Impact factor: 2.673

Review 4.  Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression.

Authors:  Michael K Wendt; Maozhen Tian; William P Schiemann
Journal:  Cell Tissue Res       Date:  2011-06-21       Impact factor: 5.249

5.  Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors.

Authors:  Tressa M Allington; Amy J Galliher-Beckley; William P Schiemann
Journal:  FASEB J       Date:  2009-08-18       Impact factor: 5.191

6.  Preclinical efficacy of cystatin C to target the oncogenic activity of transforming growth factor Beta in breast cancer.

Authors:  Maozhen Tian; William P Schiemann
Journal:  Transl Oncol       Date:  2009-08-18       Impact factor: 4.243

7.  X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progression.

Authors:  Jason R Neil; Maozhen Tian; William P Schiemann
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

Review 8.  TGFbeta as a potential mediator of progesterone action in the mammary gland of pregnancy.

Authors:  Jenifer Monks
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-11-20       Impact factor: 2.673

9.  p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity.

Authors:  Michael K Wendt; Jason A Smith; William P Schiemann
Journal:  J Biol Chem       Date:  2009-10-12       Impact factor: 5.157

10.  Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.

Authors:  Michael K Wendt; William P Schiemann
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.